Table 3.
Chemotherapy (n = 41), n (%) | Decitabine priming (n = 40), n (%) | p value | |
---|---|---|---|
OR | 21 (51.2%) | 30 (75.0%) | 0.027 |
CR | 12 (29.3%) | 22 (55.0%) | 0.019 |
PR | 0 | 0 | – |
mCR/HI | 9 (22.0%) | 8 (20.0%) | 0.829 |
SD | 8 (19.5%) | 3 (7.5%) | 0.115 |
Failure | 12 (29.3%) | 7 (17.5%) | 0.211 |
CR complete remission, PR partial remission, mCR/HI marrow complete remission/hematologic improvement, SD stable disease, failure treatment failure, OR overall response (CR + PR + mCR/HI)